ANI Pharmaceuticals
ANIP
ANIP
146 hedge funds and large institutions have $337M invested in ANI Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 23 closing their positions.
Holders
146
Holders Change
-5
Holders Change %
-3.31%
% of All Funds
3.65%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
65
Reduced
28
Closed
23
Calls
$1.72M
Puts
$14M
Net Calls
-$12.3M
Net Calls Change
-$3.52M
Top Buyers
1 |
1
BlackRock
New York
|
$66.9M |
2 |
WAM
2
Weiss Asset Management
Boston,
Massachusetts
|
$8.14M |
3 |
MP
3
Mangrove Partners
Greenwich,
Connecticut
|
$19.8M |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$5.4M |
5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$22.3M |